139 related articles for article (PubMed ID: 17881136)
21. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
Engler H; Doenlen R; Riether C; Engler A; Niemi MB; Besedovsky HO; del Rey A; Pacheco-López G; Feldon J; Schedlowski M
Brain Behav Immun; 2009 May; 23(4):518-26. PubMed ID: 19486644
[TBL] [Abstract][Full Text] [Related]
22. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort.
Qin Z; Zhang L; Sun F; Liu H; Fang X; Chan P;
Clin Neurol Neurosurg; 2009 Nov; 111(9):733-7. PubMed ID: 19665835
[TBL] [Abstract][Full Text] [Related]
23. Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes.
Pamplona R; Ilieva E; Ayala V; Bellmunt MJ; Cacabelos D; Dalfo E; Ferrer I; Portero-Otin M
Ann N Y Acad Sci; 2008 Apr; 1126():315-9. PubMed ID: 18079479
[TBL] [Abstract][Full Text] [Related]
24. [Depression in Parkinson disease. Clinical and etiopathogenic aspects].
Jeanneau A; Olie JP
Ann Med Interne (Paris); 1994; 145(4):241-6. PubMed ID: 8092649
[No Abstract] [Full Text] [Related]
25. [Neuropsychiatric problems in patients with Parkinson's disease].
Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
[TBL] [Abstract][Full Text] [Related]
26. [Dementia in Parkinson disease].
Haan J; Roos RA; Buruma OJ
Ned Tijdschr Geneeskd; 1988 Feb; 132(9):383-6. PubMed ID: 3279328
[No Abstract] [Full Text] [Related]
27. A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease.
Khusnutdinova E; Gilyazova I; Ruiz-Pesini E; Derbeneva O; Khusainova R; Khidiyatova I; Magzhanov R; Wallace DC
Ann N Y Acad Sci; 2008 Dec; 1147():1-20. PubMed ID: 19076426
[TBL] [Abstract][Full Text] [Related]
28. Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease.
Levy JA; Chelune GJ
J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):227-38. PubMed ID: 18004009
[TBL] [Abstract][Full Text] [Related]
29. Neuroimaging of nonmotor features of Parkinson's disease.
Deblieck C; Wu AD
Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
[TBL] [Abstract][Full Text] [Related]
30. [Depressive symptoms and the Idiopathic Parkinson's Syndrome (IPS): a review].
Giupponi G; Pycha R; Erfurth A; Hausmann A; Conca A
Neuropsychiatr; 2008; 22(2):71-82. PubMed ID: 18606109
[TBL] [Abstract][Full Text] [Related]
31. Autonomic dysfunction in RBD--what can it teach us about disease progression?
Postuma RB; Gagnon JF; Montplaisir J
Sleep Med; 2008 Jul; 9(5):473-4. PubMed ID: 18024175
[No Abstract] [Full Text] [Related]
32. [The relevance of dopamine agonists in the treatment of depression].
Clausius N; Born C; Grunze H
Neuropsychiatr; 2009; 23(1):15-25. PubMed ID: 19272288
[TBL] [Abstract][Full Text] [Related]
33. Progress in Parkinson's disease-where do we stand?
Toulouse A; Sullivan AM
Prog Neurobiol; 2008 Aug; 85(4):376-92. PubMed ID: 18582530
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
35. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease.
Kibel A; Drenjancević-Perić I
Med Hypotheses; 2008 Dec; 71(6):952-6. PubMed ID: 18718724
[TBL] [Abstract][Full Text] [Related]
36. Application of depression criteria (DSM-IV) in patients with Parkinson's disease.
Gómez-Esteban JC; Tijero B; Somme J; Bilbao I; Fernández J; Boyero S; Velasco F; Lezcano E; Zarranz JJ
Clin Neurol Neurosurg; 2009 Oct; 111(8):665-9. PubMed ID: 19589638
[TBL] [Abstract][Full Text] [Related]
37. Prevention of common neurodegenerative disorders in the elderly.
Fratiglioni L; Qiu C
Exp Gerontol; 2009; 44(1-2):46-50. PubMed ID: 18620039
[TBL] [Abstract][Full Text] [Related]
38. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.
Anisman H; Merali Z; Hayley S
Prog Neurobiol; 2008 May; 85(1):1-74. PubMed ID: 18346832
[TBL] [Abstract][Full Text] [Related]
39. Psychiatric aspects of Parkinson's disease.
Baldwin RC; Byrne EJ
BMJ; 1989 Jul; 299(6690):3-4. PubMed ID: 2503201
[No Abstract] [Full Text] [Related]
40. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
Montel S; Bonnet AM; Bungener C
J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):95-102. PubMed ID: 19150974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
